vimarsana.com


A new drug that could help more than 128 million Americans read without needing glasses has been submitted to the Food and Drug Administration for approval.  
The eye drops are a pilocarpine solution meant to treat the symptoms of presbyopia, an age-related condition that causes gradual loss of the eyes’ ability to focus on nearby objects, according to the Mayo Clinic.
It’s a natural but annoying part of aging, said Dr. Robert S. Bailey, chief of the Cataract and Primary Eye Care Service at Wills Eye Hospital in Philadelphia.
“It happens from (the age) of 10 and then you gradually lose that focusing ability to the age of 70 when you lose the ability totally,” he said. Most patients begin to notice it in their mid-40s.

Related Keywords

Wills Eye Hospital ,Pennsylvania ,United States ,Philadelphia ,Americans ,Roberts Bailey , ,Eye Care Service At Wills Hospital ,Drug Administration ,Allergan Eye Car ,Primary Eye Care Service ,உயில் கண் மருத்துவமனை ,பென்சில்வேனியா ,ஒன்றுபட்டது மாநிலங்களில் ,பிலடெல்பியா ,அமெரிக்கர்கள் ,ராபர்ட்ஸ் பெய்லி ,கண் பராமரிப்பு சேவை இல் உயில் மருத்துவமனை ,ஒவ்வாமை கண் கார் ,ப்ரைமரீ கண் பராமரிப்பு சேவை ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.